Funding for this research was provided by:
Sunchon National University
Article History
Received: 29 December 2022
Accepted: 13 February 2023
First Online: 11 March 2023
Declarations
:
: All authors (J.H. Jang, S.H. Jeong, and Y.B. Lee) have no conflicts of interest relevant to this study to disclose.
: This study protocol was thoroughly reviewed and approved by the Institutional Review Board of the Institute of Bioequivalence and Bridging Study, Chonnam National University, Gwangju, Republic of Korea. The bioequivalence study permit number was as follows: 926; 04.22.2006.
: All subjects provided written informed consent prior to their participation in bioequivalence and pharmacokinetic studies.
: All data were anonymized and participants were informed that the results of this study may be subject to publication and presentation in meetings.
: The clinical study protocol used in this study was thoroughly reviewed and approved by the Institutional Review Board of the Institute of Bioequivalence and Bridging Study, Chonnam National University, Gwangju, Republic of Korea. The bioequivalence study permit numbers are as follows: 926; 04.22.2006.